Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2012, Article ID 796751, 12 pages
http://dx.doi.org/10.1155/2012/796751
Review Article

Prevention of Post-ERCP Pancreatitis

Department of Gastroenterology, Division of Medicine, Vancouver General Hospital, Vancouver, BC, Canada V5Z 1M9

Received 31 May 2011; Accepted 13 June 2011

Academic Editor: Fauze Maluf-Filho

Copyright © 2012 F. Donnellan and Michael F. Byrne. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. B. Cotton, G. Lehman, J. Vennes et al., “Endoscopic sphincterotomy complications and their management: an attempt at consensus,” Gastrointestinal Endoscopy, vol. 37, no. 3, pp. 383–393, 1991. View at Google Scholar · View at Scopus
  2. M. L. Freeman, D. B. Nelson, S. Sherman et al., “Complications of endoscopic biliary sphincterotomy,” The New England Journal of Medicine, vol. 335, no. 13, pp. 909–918, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Andriulli, S. Loperfido, G. Napolitano et al., “Incidence rates of post-ERCP complications: a systematic survey of prospective studies,” The American Journal of Gastroenterology, vol. 102, no. 8, pp. 1781–1788, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Masci, A. Mariani, S. Curioni, and P. A. Testoni, “Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis,” Endoscopy, vol. 35, no. 10, pp. 830–834, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. A. Testoni, A. Mariani, and A. Giussani, “Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study,” The The American Journal of Gastroenterology, vol. 105, no. 8, pp. 1753–1761, 2010. View at Google Scholar
  6. C. L. Cheng, S. Sherman, J. L. Watkins et al., “Risk factors for post-ERCP pancreatitis: a prospective multicenter study,” The American Journal of Gastroenterology, vol. 101, no. 1, pp. 139–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Freeman, J. A. DiSario, D. B. Nelson et al., “Risk factors for post-ERCP pancreatitis: a prospective, multicenter study,” Gastrointestinal Endoscopy, vol. 54, no. 4, pp. 425–434, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. E. J. Williams, S. Taylor, P. Fairclough et al., “Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study,” Endoscopy, vol. 39, no. 9, pp. 793–801, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Bailey, M. J. Bourke, S. J. Williams et al., “A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis,” Endoscopy, vol. 40, no. 4, pp. 296–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. L. A. Artifon, P. Sakai, J. E. M. Cunha, B. Halwan, S. Ishioka, and A. Kumar, “Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation,” The American Journal of Gastroenterology, vol. 102, no. 10, pp. 2147–2153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. H. Lee, D. H. Park, J. Y. Park et al., “Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial,” Gastrointestinal Endoscopy, vol. 69, no. 3, pp. 444–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Cheung, K. K. Tsoi, W. L. Quan, J. Y. W. Lau, and J. J. Y. Sung, “Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis,” Gastrointestinal Endoscopy, vol. 70, no. 6, pp. 1211–1219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Vandervoort, R. M. Soetikno, T. C. K. Tham et al., “Risk factors for complications after performance of ERCP,” Gastrointestinal Endoscopy, vol. 56, no. 5, pp. 652–656, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. K. Cheon, K. B. Cho, J. L. Watkins et al., “Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification{A figure is presented},” Gastrointestinal Endoscopy, vol. 65, no. 3, pp. 385–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Dumonceau, A. Andriulli, J. Deviere et al., “European Society of Gastrointestinal Endoscopy (ESGE)Guideline: prophylaxis of post-ERCP pancreatitis,” Endoscopy, vol. 42, no. 6, pp. 503–515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. S. Barkin, G. L. Casal, D. K. Reiner, R. I. Goldberg, R. S. Phillips, and S. Kaplan, “A comparative study of contrast agents for endoscopic retrograde pancreatography,” The American Journal of Gastroenterology, vol. 86, no. 10, pp. 1437–1441, 1991. View at Google Scholar · View at Scopus
  17. G. K. Johnson, J. E. Geenen, R. A. Bedford et al., “A comparision of nonionic versus ionic contrast media: results of a prospective multicenter study,” Gastrointestinal Endoscopy, vol. 42, no. 4, pp. 312–316, 1995. View at Google Scholar
  18. S. George, A. A. Kulkarni, G. Stevens, C. E. Forsmark, and P. Draganov, “Role of osmolality of contrast media in the development of post-ERCP pancreatitis: a metanalysis,” Digestive Diseases and Sciences, vol. 49, no. 3, pp. 503–508, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Dumonceau, J. Deviere, and M. Cremer, “A new method of achieving deep cannulation of the common bile duct during endoscopic retrograde cholangiopancreatography,” Endoscopy, vol. 30, no. 7, p. S80, 1998. View at Google Scholar · View at Scopus
  20. S. Maeda, H. Hayashi, O. Hosokawa et al., “Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement,” Endoscopy, vol. 35, no. 9, pp. 721–724, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Herreros de Tejada, J. L. Calleja, G. Díaz et al., “Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial,” Gastrointestinal Endoscopy, vol. 70, no. 4, pp. 700–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Ito, N. Fujita, Y. Noda et al., “Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial,” Journal of Gastroenterology, vol. 45, no. 11, pp. 1183–1191, 2010. View at Google Scholar
  23. A. Smithline, W. Silverman, D. Rogers et al., “Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients,” Gastrointestinal Endoscopy, vol. 39, no. 5, pp. 652–657, 1993. View at Google Scholar · View at Scopus
  24. S. Sherman, D. T. Earle, L. Bucksot et al., “Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study,” Gastrointestinal Endoscopy, vol. 43, p. A486, 1996. View at Google Scholar
  25. E. Elton, D. A. Howell, W. G. Parsons, T. Qaseem, and B. L. Hanson, “Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique,” Gastrointestinal Endoscopy, vol. 47, no. 3, pp. 240–249, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. P. R. Tarnasky, Y. Y. Palesch, J. T. Cunningham, P. D. Mauldin, P. B. Cotton, and R. H. Hawes, “Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction,” Gastroenterology, vol. 115, no. 6, pp. 1518–1524, 1998. View at Google Scholar · View at Scopus
  27. R. Patel, P. Tarnasky, W. S. Hennessy et al., “Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized controlled trial,” Gastrointestinal Endoscopy, vol. 49, p. AB80, 1999. View at Google Scholar
  28. T. Aizawa and N. Ueno, “Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones,” Gastrointestinal Endoscopy, vol. 54, no. 2, pp. 209–213, 2001. View at Google Scholar · View at Scopus
  29. A. Fazel, A. Quadri, M. F. Catalano, S. M. Meyerson, and J. E. Geenen, “Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study,” Gastrointestinal Endoscopy, vol. 57, no. 3, pp. 291–294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sofuni, H. Maguchi, T. Itoi et al., “Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent,” Clinical Gastroenterology and Hepatology, vol. 5, no. 11, pp. 1339–1346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Tsuchiya, T. Itoi, A. Sofuni et al., “Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 14, no. 3, pp. 302–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Choudhary, M. L. Bechtold, M. Arif et al., “Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review,” Gastrointestinal Endoscopy, vol. 73, no. 2, pp. 275–282, 2011. View at Google Scholar
  33. M. L. Freeman, “Pancreatic Stents for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis,” Clinical Gastroenterology and Hepatology, vol. 5, no. 11, pp. 1354–1365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Brackbill, S. Young, P. Schoenfeld, and G. Elta, “A survey of physician practices on prophylactic pancreatic stents,” Gastrointestinal Endoscopy, vol. 64, no. 1, pp. 45–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. M. Guda, M. F. Catalano, and J. E. Geenen, “Post ERCP pancreatitis: differences in outcomes between 3 Fr long Pigtail and modified short 5 Fr Geenen stents: a randomized controlled trial,” Gastrointestinal Endoscopy, vol. 65, p. AB113, 2007. View at Google Scholar
  36. P. Chahal, P. R. Tarnasky, B. T. Petersen et al., “Short 5Fr vs Long 3Fr Pancreatic Stents in Patients at Risk for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis,” Clinical Gastroenterology and Hepatology, vol. 7, no. 8, pp. 834–839, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. L. Freeman, “Complications of endoscopic biliary sphincterotomy: a review,” Endoscopy, vol. 29, no. 4, pp. 288–297, 1997. View at Google Scholar · View at Scopus
  38. D. Verma, A. Kapadia, and D. G. Adler, “Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes,” Gastrointestinal Endoscopy, vol. 66, no. 2, pp. 283–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. H. Elta, J. L. Barnett, R. T. Wille, K. A. Brown, W. D. Chey, and J. M. Scheiman, “Pure cut electrocautery current for sphincterotomy causes less post- procedure pancreatitis than blended current,” Gastrointestinal Endoscopy, vol. 47, no. 2, pp. 149–153, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Stefanidis, G. Karamanolis, N. Viazis et al., “A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis,” Gastrointestinal Endoscopy, vol. 57, no. 2, pp. 192–197, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. D. G. MacIntosh, J. Love, and N. S. Abraham, “Endoscopic sphincterotomy by using pure-cut electrosurgical current and the risk of post-ERCP pancreatitis: a prospective randomized trial,” Gastrointestinal Endoscopy, vol. 60, no. 4, pp. 551–556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. I. D. Norton, B. T. Petersen, J. Bosco et al., “A randomized trial of endoscopic biliary sphincterotomy using pure-cut versus combined cut and coagulation waveforms,” Clinical Gastroenterology and Hepatology, vol. 3, no. 10, pp. 1029–1033, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Yasuda, E. Tomita, M. Enya, T. Kato, and H. Moriwaki, “Can endoscopic papillary balloon dilation really preserve sphincter of oddi function?” Gut, vol. 49, no. 5, pp. 686–691, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. T. H. Baron and G. C. Harewood, “Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials,” The American Journal of Gastroenterology, vol. 99, no. 8, pp. 1455–1460, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. J. J. G. H. M. Bergman, A. M. Van Berkel, M. J. Bruno et al., “A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy,” Gastrointestinal Endoscopy, vol. 53, no. 1, pp. 19–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. J. A. Disario, M. L. Freeman, D. J. Bjorkman et al., “Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones,” Gastroenterology, vol. 127, no. 5, pp. 1291–1299, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Maydeo and S. Bhandari, “Balloon sphincteroplasty for removing difficult bile duct stones,” Endoscopy, vol. 39, no. 11, pp. 958–961, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. H. Heo, D. H. Kang, H. J. Jung et al., “Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones,” Gastrointestinal Endoscopy, vol. 66, no. 4, pp. 720–726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Loperfido, G. Angelini, G. Benedetti et al., “Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study,” Gastrointestinal Endoscopy, vol. 48, no. 1, pp. 1–10, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Manes, P. Di Giorgio, A. Repici, G. MacArri, S. Ardizzone, and G. B. Porro, “An analysis of the factors associated with the development of complications in patients undergoing precut sphincterotomy: a prospective, controlled, randomized, multicenter study,” The American Journal of Gastroenterology, vol. 104, no. 10, pp. 2412–2417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Cennamo, L. Fuccio, A. Repici et al., “Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study,” Gastrointestinal Endoscopy, vol. 69, no. 3, pp. 473–479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Cennamo, L. Fuccio, R. M. Zagari et al., “Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials,” Endoscopy, vol. 42, no. 5, pp. 381–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Mavrogiannis, C. Liatsos, A. Romanos, C. Petoumenos, A. Nakos, and G. Karvountzis, “Needle-knife fistulotomy versus needle-knife precut papillotomy for the treatment of common bile duct stones,” Gastrointestinal Endoscopy, vol. 50, pp. 334–339, 1999. View at Google Scholar
  54. E. M. Abu-Hamda, T. H. Baron, D. T. Simmons, and B. T. Petersen, “A retrospective comparison of outcomes using three different precut needle knife techniques for biliary cannulation,” Journal of Clinical Gastroenterology, vol. 39, no. 8, pp. 717–721, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Sherman, F. P. Troiano, R. H. Hawes, and G. A. Lehman, “Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter,” Gastrointestinal Endoscopy, vol. 36, no. 5, pp. 462–466, 1990. View at Google Scholar · View at Scopus
  56. P. Rolny, B. Anderberg, I. Ihse, E. Lindstrom, G. Olaison, and A. Arvill, “Pancreatitis after sphincter of Oddi manometry,” Gut, vol. 31, no. 7, pp. 821–824, 1990. View at Google Scholar · View at Scopus
  57. S. Sherman, R. H. Hawes, F. P. Troiano, and G. A. Lehman, “Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter,” Gastrointestinal Endoscopy, vol. 38, no. 3, pp. 347–350, 1992. View at Google Scholar · View at Scopus
  58. M. E. Maldonado, P. G. Brady, J. J. Mamel, and B. Robinson, “Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM),” The American Journal of Gastroenterology, vol. 94, no. 2, pp. 387–390, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. K. F. Binmoeller, S. Boaventura, K. Ramsperger, and N. Soehendra, “Endoscopic snare excision of benign adenomas of the papilla of Vater,” Gastrointestinal Endoscopy, vol. 39, no. 2, pp. 127–131, 1993. View at Google Scholar · View at Scopus
  60. Z. Zádorová, M. Dvořák, and J. Hajer, “Endoscopic therapy of benign tumors of the papilla of Vater,” Endoscopy, vol. 33, no. 4, pp. 345–347, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. C. L. Cheng, S. Sherman, E. L. Fogel et al., “Endoscopic snare papillectomy for tumors of the duodenal papillae,” Gastrointestinal Endoscopy, vol. 60, no. 5, pp. 757–764, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. G. C. Harewood, N. L. Pochron, and C. J. Gostout, “Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla,” Gastrointestinal Endoscopy, vol. 62, no. 3, pp. 367–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. J. A. Viedma, M. Perez-Mateo, J. Agullo, J. E. Dominguez, and F. Carballo, “Inflammatory response in the early prediction of severity in human acute pancreatitis,” Gut, vol. 35, no. 6, pp. 822–827, 1994. View at Google Scholar · View at Scopus
  64. B. J. Elmunzer, A. K. Waljee, G. H. Elta, J. R. Taylor, S. M. A. Fehmi, and P. D. R. Higgins, “A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis,” Gut, vol. 57, no. 9, pp. 1262–1267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. K. Cheon, K. B. Cho, J. L. Watkins et al., “Efficacy of diclofenac in the prevention of post-ERCP pancreatitisinpredominantly high-risk patients: a randomized double-blind prospective trial,” Gastrointestinal Endoscopy, vol. 66, no. 6, pp. 1126–1132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. N. M. Davies and K. E. Andersen, “Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls,” Clinical Pharmacokinetics, vol. 33, no. 3, pp. 184–213, 1997. View at Google Scholar · View at Scopus
  67. A. J. Kaffes, M. J. Bourke, S. Ding, A. Alrubaie, V. Kwan, and S. J. Williams, “A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis,” Gastrointestinal Endoscopy, vol. 64, no. 3, pp. 351–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Moretó, M. Zaballa, I. Casado et al., “Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial,” Gastrointestinal Endoscopy, vol. 57, no. 1, pp. 1–7, 2003. View at Google Scholar
  69. Y. Bai, C. Xu, X. Yang, J. Gao, D. W. Zou, and Z. S. Li, “Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials,” Endoscopy, vol. 41, no. 8, pp. 690–695, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. U. C. Bang, C. Nojgaard, P. K. Andersen, and P. Matzen, “Meta-analysis: nitroglycerin for prevention of post-ERCP pancreatitis,” Alimentary Pharmacology & Therapeutics, vol. 29, pp. 1078–1085, 2009. View at Google Scholar
  71. L. M. Shao, Q. Y. Chen, M. Y. Chen, and J. T. Cai, “Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis,” Digestive Diseases and Sciences, vol. 55, no. 1, pp. 1–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Räty, J. Sand, M. Pulkkinen, M. Matikainen, and I. Nordback, “Post-ERCP pancreatitis: reduction by routine antibiotics,” Journal of Gastrointestinal Surgery, vol. 5, no. 4, pp. 339–345, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. Z. Tulassay and J. Papp, “The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography,” Gastrointestinal Endoscopy, vol. 37, no. 1, pp. 48–50, 1991. View at Google Scholar · View at Scopus
  74. A. Andriulli, G. Leandro, T. Federici et al., “Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis,” Gastrointestinal Endoscopy, vol. 65, no. 4, pp. 624–632, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Rudin, A. Kiss, R. V. Wetz, and V. M. Sottile, “Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials,” Journal of Gastroenterology and Hepatology, vol. 22, no. 7, pp. 977–983, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. K. C. Thomopoulos, N. A. Pagoni, K. A. Vagenas, V. G. Margaritis, G. I. Theocharis, and V. N. Nikolopoulou, “Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis,” Gastrointestinal Endoscopy, vol. 64, no. 5, pp. 726–731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. P. A. Testoni, F. Bagnolo, A. Andriulli et al., “Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial,” Alimentary Pharmacology & Therapeutics, vol. 15, no. 7, pp. 965–972, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Bai, J. Gao, D. W. Zou, and Z. S. Li, “Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials,” Pancreas, vol. 37, no. 3, pp. 241–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Zhang, Q. B. Chen, Z. Y. Gao, and W. F. Xie, “Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses,” Alimentary Pharmacology & Therapeutics, vol. 29, no. 11, pp. 1155–1164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. G. S. Xiong, S. M. Wu, X. W. Zhang, and Z. Z. Ge, “Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis,” Brazilian Journal of Medical and Biological Research, vol. 39, no. 1, pp. 85–90, 2006. View at Google Scholar · View at Scopus
  81. G. Manes, S. Ardizzone, G. Lombardi, G. Uomo, O. Pieramico, and G. B. Porro, “Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study,” Gastrointestinal Endoscopy, vol. 65, no. 7, pp. 982–987, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Andriulli, R. Clemente, L. Solmi et al., “Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial,” Gastrointestinal Endoscopy, vol. 56, no. 4, pp. 488–495, 2002. View at Google Scholar · View at Scopus
  83. A. Andriulli, L. Solmi, S. Loperfido et al., “Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate,” Clinical Gastroenterology and Hepatology, vol. 2, no. 8, pp. 713–718, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. B. M. Jonsson-Berling and K. Ohlsson, “Distribution and elimination of intravenously injected urinary trypsin inhibitor,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 51, no. 6, pp. 549–557, 1991. View at Google Scholar · View at Scopus
  85. T. Tsujino, Y. Komatsu, H. Isayama et al., “Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial,” Clinical Gastroenterology and Hepatology, vol. 3, no. 4, pp. 376–383, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. J. W. Yoo, J. K. Ryu, S. H. Lee et al., “Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial,” Pancreas, vol. 37, no. 4, pp. 366–370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Chen, H. Shi, X. Zou, and H. Luo, “Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's new clothes or Aladdin's magic lamp?” Pancreas, vol. 39, no. 8, pp. 1231–1237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. C. W. Choi, D. H. Kang, G. H. Kim et al., “Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis,” Gastrointestinal Endoscopy, vol. 69, no. 4, pp. e11–e18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. K. S. Yoo, K. R. Huh, Y. J. Kim et al., “Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial,” Pancreas, vol. 40, no. 2, pp. 181–186, 2011. View at Google Scholar
  90. T. Seta and Y. Noguchi, “Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis,” Gastrointestinal Endoscopy, vol. 73, no. 4, pp. 700–706, 2011. View at Google Scholar
  91. H. Sanfey and J. L. Cameron, “Increased capillary permeability: an early lesion in acute pancreatitis,” Surgery, vol. 96, no. 3, pp. 485–491, 1984. View at Google Scholar · View at Scopus
  92. H. Sanfey, G. B. Bulkley, and J. L. Cameron, “The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis,” Annals of Surgery, vol. 200, no. 4, pp. 405–413, 1984. View at Google Scholar · View at Scopus
  93. J. M. Marks, B. J. Dunkin, B. L. Shillingstad et al., “Pretreatment with allopurinol diminishes pancreatography-induced pancreatitis in a canine model,” Gastrointestinal Endoscopy, vol. 48, no. 2, pp. 180–183, 1998. View at Google Scholar · View at Scopus
  94. P. Katsinelos, J. Kountouras, J. Chatzis et al., “High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial,” Gastrointestinal Endoscopy, vol. 61, no. 3, pp. 407–415, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Martinez-Torres, X. Rodriguez-Lomeli, C. Davalos-Cobian et al., “Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography,” World Journal of Gastroenterology, vol. 15, no. 13, pp. 1600–1606, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Mosler, S. Sherman, J. Marks et al., “Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis,” Gastrointestinal Endoscopy, vol. 62, no. 2, pp. 245–250, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Romagnuolo, R. Hilsden, G. S. Sandha et al., “Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial,” Clinical Gastroenterology and Hepatology, vol. 6, no. 4, pp. 465–471, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Zheng, Y. Chen, J. Bai, Y. Xin, X. Pan, and L. Zhao, “Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis,” Pancreas, vol. 37, no. 3, pp. 247–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Sherman, U. Blaut, J. L. Watkins et al., “Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study,” Gastrointestinal Endoscopy, vol. 58, no. 1, pp. 23–29, 2003. View at Google Scholar
  100. P. Toulon, G. Chadeuf, J. L. Bouillot et al., “Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in man,” European Journal of Clinical Investigation, vol. 21, no. 3, pp. 303–309, 1991. View at Google Scholar · View at Scopus
  101. T. Rabenstein, B. Fischer, V. Wiessner et al., “Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis,” Gastrointestinal Endoscopy, vol. 59, no. 6, pp. 606–613, 2004. View at Google Scholar
  102. G. Yagci, H. Gul, A. Simsek et al., “Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats,” Journal of Gastroenterology, vol. 39, no. 3, pp. 268–276, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Katsinelos, J. Kountouras, G. Paroutoglou, A. Beltsis, K. Mimidis, and C. Zavos, “Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis,” Gastrointestinal Endoscopy, vol. 62, pp. 105–111, 2005. View at Google Scholar
  104. J. Milewski, G. Rydzewska, M. Degowska, M. Kierzkiewicz, and A. Rydzewski, “N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis,” World Journal of Gastroenterology, vol. 12, no. 23, pp. 3751–3755, 2006. View at Google Scholar · View at Scopus